SUBSCRIBE Subscribe to our RSS Feed

CMLHope.Com

A Worldwide Support Network For Chronic Myelogenous Leukemia

  • home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Archives

  • June 2013
  • March 2013
  • February 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • May 2012
  • March 2012
  • February 2012
  • January 2012
  • October 2011
  • September 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • February 2006
  • January 2006
  • December 2005
  • November 2005
  • October 2005
  • September 2005
  • August 2005
  • July 2005
  • June 2005
  • May 2005
  • April 2005
  • March 2005
  • February 2005
  • January 2005
  • December 2004
  • November 2004
  • October 2004
  • September 2004
  • August 2004
  • July 2004
  • June 2004

Recent Posts

  • SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.
  • Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.
  • Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
  • PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia.
  • Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient.
  • Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
  • Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission.
  • Synthesis, characterization and biological evaluation of some novel P-heterocyclic androst-4-ene derivatives.
  • 2-Cinnamamido, 2-(3-phenylpropiolamido), and 2-(3-phenylpropanamido)benzamides: Synthesis, antiproliferative activity, and mechanism of action.
  • Photo-bio-synthesis of irregular shaped functionalized gold nanoparticles using edible mushroom Pleurotus florida and its anticancer evaluation.
  • miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein.
  • SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.
  • Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib.
  • Dural metastases in chronic myeloid leukemia presenting as subdural hematoma.
  • Extranodal Marginal Zone Lymphoma Arising in a Chronic Myelogenous Leukemia Patient on Long-Term Tyrosine Kinase Inhibitors.
May 2008
M T W T F S S
« Apr   Jun »
 1234
567891011
12131415161718
19202122232425
262728293031  

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Medical Articles 5/10

Posted by rob on May 10, 2008 under Uncategorized | Be the First to Comment

Immunophenotypic study of basophils by multiparameter flow cytometry.

Information is temporarily unavailable.

Omacetaxine
mepesuccinate – a semisynthetic formulation of the natural antitumoral
alkaloid homoharringtonine, for chronic myelocytic leukemia and other
myeloid malignancies.

home top

Site Information

© 2013 CMLHope.Com
Ministry Free Theme
by eGrace Creative.

Pages

  • Home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Blogroll

    Contributors

    • MedWorm Query: +chronic +myelogenous +leukemia
    • pubmed: myelogenous